Barreiro P - Search Results

1

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.

Labarga P, Barreiro P, da Silva A, Guardiola JM, Rubio R, Aguirrebengoa K, Miralles P, Portu J, Téllez MJ, Morano L, Castro A, Pineda JA, Terrón A, Hernández-Quero J, Mariño A, Ríos MJ, Echeverría S, Asensi V, Vispo E, Soriano V; PERICO Study Group. Labarga P, et al. Among authors: barreiro p. J Infect Dis. 2012 Sep 15;206(6):961-8. doi: 10.1093/infdis/jis449. Epub 2012 Jul 17. J Infect Dis. 2012. PMID: 22807523 Clinical Trial.

2

Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.

Barreiro PM, Dona MC, Castilla J, Soriano V. Barreiro PM, et al. AIDS. 1999 Mar 11;13(4):525-6. doi: 10.1097/00002030-199903110-00014. AIDS. 1999. PMID: 10197384 No abstract available.

3

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

Soriano V, Dona C, Rodríguez-Rosado R, Barreiro P, González-Lahoz J. Soriano V, et al. Among authors: barreiro p. AIDS. 2000 Mar 10;14(4):383-6. doi: 10.1097/00002030-200003100-00011. AIDS. 2000. PMID: 10770540

4

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.

Barreiro P, Soriano V, Blanco F, Casimiro C, de la Cruz JJ, González-Lahoz J. Barreiro P, et al. AIDS. 2000 May 5;14(7):807-12. doi: 10.1097/00002030-200005050-00006. AIDS. 2000. PMID: 10839588 Clinical Trial.

5

Potent activity but limited tolerance of ritonavir plus indinavir in salvage interventions.

Barreiro P, Soriano V, Oller V, González-Lahoz J. Barreiro P, et al. J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):488. doi: 10.1097/00126334-200008150-00015. J Acquir Immune Defic Syndr. 2000. PMID: 11035621 No abstract available.

6

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids.

Barreiro P, Soriano V, Casas E, Estrada V, Téllez MJ, Hoetelmans R, de Requena DG, Jimenéz-Nácher I, González-Lahoz J. Barreiro P, et al. AIDS. 2000 Sep 29;14(14):2153-7. doi: 10.1097/00002030-200009290-00012. AIDS. 2000. PMID: 11061657 Clinical Trial.

7

[Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program].

Dona C, Soriano V, Barreiro P, Jiménez-Náchera I, González-Lahoz J. Dona C, et al. Among authors: barreiro p. Med Clin (Barc). 2000 Sep 23;115(9):337-8. doi: 10.1016/s0025-7753(00)71549-1. Med Clin (Barc). 2000. PMID: 11093894 Spanish.

8

Induction-maintenance (5 --> 3 drugs) in HIV-infected patients with high viral load.

Soriano V, Barreiro P, Gonzalez-Lahoz J. Soriano V, et al. Among authors: barreiro p. AIDS Patient Care STDS. 2000 Nov;14(11):573-4. doi: 10.1089/10872910050193734. AIDS Patient Care STDS. 2000. PMID: 11155897 No abstract available.

9

Tolerability of abacavir in the clinical setting.

Martín-Carbonero L, Barreiro P, Soriano V, González-Lahoz J. Martín-Carbonero L, et al. Among authors: barreiro p. Clin Microbiol Infect. 2000 Nov;6(11):621-2. doi: 10.1046/j.1469-0691.2000.00162.x. Clin Microbiol Infect. 2000. PMID: 11168068 Free article. No abstract available.

10

Is there a role for indinavir twice-daily in clinical practice?

Barreiro P, Soriano V, Cabello N, González-Lahoz J. Barreiro P, et al. Clin Microbiol Infect. 2000 Mar;6(3):152-4. doi: 10.1046/j.1469-0691.2000.00034-3.x. Clin Microbiol Infect. 2000. PMID: 11168093 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters